Dan Margolies
Reporter and Editor, KCURDan Margolies is editor in charge of health news at KCUR, the public radio station in Kansas City. Dan joined KCUR in April 2014. In a long and varied journalism career, he has worked as a reporter for the Kansas City Business Journal, The Kansas City Star and Reuters. In a previous life, he was a lawyer. He has also worked as a media insurance underwriter and project development director for a video production firm.
Dan was born in Brooklyn, NY, and moved to Kansas City with his family when he was eight years old. He majored in philosophy at Washington University in St. Louis and holds law and journalism degrees from Boston University.
He is a two-time finalist for the Gerald Loeb Awards for Distinguished Business and Financial Journalism and the recipient of numerous first-place awards from the Missouri Press Association, Kansas City Press Club and the Association of Area Business Publications.
-
Aviva joined KCUR in 2019, impressing her colleagues with her work ethic and strength of purpose.
-
Frazier Glenn Miller Jr., a self-avowed anti-Semite, testified that he drove to Overland Park from his Aurora, Missouri, home looking to murder Jews. None of his victims turned out to be Jewish.
-
Mark Wisner was convicted of aggravated sexual battery and aggravated criminal assault in 2017 and sentenced to nearly 16 years in prison.
-
The increases come amid worker shortages caused by the COVID-19 pandemic. It's has strained hospitals’ capacity and word down employees.
-
Shawn Parcells is awaiting trial in Wabaunsee County on three felony counts of theft and three misdemeanor counts of criminal desecration.
-
Multiple patients complained to the VA about the conduct of Mark Wisner, a physician assistant, during the years he treated both veterans.
-
Gov. Laura Kelly, who has already named two justices to the high court, has 60 days within which to pick one of the three.
-
The two locations at 75th Street and Metcalf Avenue and 159th Street and 69 Highway will be closed on Dec. 30.
-
The trial will allow for the introduction of multiple agents to combat COVID-19 as they become available.
-
AstraZeneca hopes to enroll 30,000 people in its Phase 3 trials in the United States. The KU/Children’s Mercy trial was looking to recruit 1,500 participants.